Famotidine is a medicine that helps people with stomach problems like gastritis and peptic ulcers.

Flare Therapeutics Unveils Design for FX-909's Early-Stage Trial with Dose Increasing and Widening Approach at ASCO's 2024 Urologic Cancer Conference.

Amoxicillin Trihydrate is a cell wall inhibitor drug used as an antibiotic to treat bacterial infections like bronchitis, pneumonia, urinary tract infections, and strep throat.

LAVA Therapeutics reveals a partnership with Merck & Co., US, to assess the potential of combining LAVA-1207 with the treatment, KEYTRUDA®.

Ibuprofen, a COX-inhibiting drug approved by Johnson & Johnson in 1978, is primarily used to manage rheumatoid arthritis, arthritis, fever, and pain.

Metoprolol Tartrate is a medication that blocks β-adrenoceptors, and it was approved in 1978 by AstraZeneca PLC.

Sionna Therapeutics has revealed the administration of the initial dose to a healthy participant in the Stage 1 clinical study for SION-109.

Atorvastatin is a medication that inhibits the HMG-CoA reductase enzyme. Hanmi Pharmaceutical Co., Ltd approved it in January 2008.

Sciwind Biosciences Reports Encouraging Outcomes from Initial Clinical Study of XW004, Its Oral Version of Sustained-Release GLP-1 Mimetic Ecnoglutide.

Trazodone, a selective inhibitor of serotonin reuptake transporter 5, has been a key treatment for depression since its approval in Dec 1981 by Angelini Pharma.

Acetaminophen, a small molecule COX enzyme inhibitor drug approved in January 1966, is widely used for pain relief and fever reduction.

Locus Biosciences has disclosed receiving a $23.9 million investment from BARDA, intended to back the inaugural Phase 2 study of its groundbreaking CRISPR-crafted phage treatment.